https://www.selleckchem.com/pr....oducts/o6-benzylguan
Results VAS pain score in ketorolac-treated eyes (median 3.0, interquatile range [IQR] ±2.5) was lower than in placebo-treated eyes (median 5.0, IQR ±3.. Total Pain Rate Index score from MPQ was lower in ketorolac-treated eyes (median 3.0, IQR ±3. than in placebo-treated eyes (median 3.0, IQR ±2.5). Both pain score differences are statistically significant with P ˂ 0.05. Conclusion Topical ketorolac tromethamine 0.5% given pre-emptively a day before is effective in alleviating pain in patients undergoing PRP treatment.A glo
إعجاب
علق
شارك
